Literature DB >> 3132827

Balloon test occlusion of the internal carotid artery with stable xenon/CT cerebral blood flow imaging.

S M Erba1, J A Horton, R E Latchaw, H Yonas, L Sekhar, V Schramm, S Pentheny.   

Abstract

We describe a technique to predict preoperatively the safety of permanently occluding an internal carotid artery. The method was performed by imaging stable xenon cerebral blood flow (CBF) with the internal carotid artery both open and temporarily occluded with a nondetachable balloon on a double lumen Swan-Ganz catheter. Patients were those in whom we planned to sacrifice the internal carotid artery (those with giant or inaccessible aneurysms) or those in whom such a sacrifice was at least likely (those with skull base tumors). Patients were divided into three groups on the basis of a comparison of occluded and nonoccluded CBF values. Group-I patients had no significant change in CBF with internal carotid artery occlusion; group-II patients showed a symmetric decrease in CBF; and group-III patients had an asymmetric decrease in CBF, always greater on the occluded side. A fourth group clinically failed to tolerate even brief carotid occlusion. The internal carotid artery in one patients from group III was sacrificed at surgery: the size and shape of his postoperative infarct corresponded almost exactly to the area of asymmetrically decreased CBF on his occluded study. The data suggest that if surgery is likely to result in permanent occlusion of the internal carotid artery, then patients who are at risk for delayed neurologic injury due to a compromised cerebral blood flow should have arterial bypass grafts before such surgery is performed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3132827      PMCID: PMC8332805     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  20 in total

1.  Carotid artery balloon test occlusion.

Authors: 
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

Review 2.  Interventional neuroradiology.

Authors:  S Renowden
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

3.  Predictive value of balloon test occlusion of the internal carotid artery.

Authors:  D H Segal; C Sen; J B Bederson; P Catalano; M Sacher; A L Stollman; M Lorberboym
Journal:  Skull Base Surg       Date:  1995

4.  Emergent middle cerebral artery embolectomy: a useful technique for cranial base surgery.

Authors:  M E Linskey; E Stephanian; L N Sekhar
Journal:  Skull Base Surg       Date:  1993

5.  Timing treatment of a giant intracranial aneurysm by the use of magnetic resonance imaging for the determination of intraluminal clot stability.

Authors:  C A Jungreis; P J Jannetta; H Yonas
Journal:  Skull Base Surg       Date:  1993

6.  Complications of preoperative balloon test occlusion of the internal carotid arteries: experience in 300 cases.

Authors:  R W Tarr; C A Jungreis; J A Horton; S Pentheny; L N Sekhar; C Sen; I P Janecka; H Yonas
Journal:  Skull Base Surg       Date:  1991

7.  Use of cerebral oximetry to monitor brain oxygenation reserves for skull base surgery.

Authors:  M Dujovny; K V Slavin; G Hernandez; G K Geremia; J I Ausman
Journal:  Skull Base Surg       Date:  1994

8.  Measurement of regional cerebral blood flow with H2(15)O positron emission tomography during Matas test. Report of three cases.

Authors:  H Katano; H Nagai; M Mase; T Banno
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Emergency balloon embolization for carotid artery rupture secondary to postoperative infection.

Authors:  T Hirai; Y Korogi; Y Sakamoto; S Hamatake; R Murakami; I Ikushima; M Takahashi
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Jan-Feb       Impact factor: 2.740

10.  Pre- and intraoperative methods of controlling cerebral circulation in giant aneurysm surgery.

Authors:  H G Boecher-Schwarz; K Ungersboeck; P Ulrich; W Mueller-Forell; D Smolders; A Perneczky
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.